A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults - NCT04584710

To determine the length of time from date of receipt of a positive SARS-CoV2 test result to date of first dose of study drug in asymptomatic adults age ≥ 65 years, To determine the feasibility of using an eDiary to assess study drug compliance in the study drug population, To determine the feasibility of using an eDiary to assess COVID-19 symptoms in the study population, (and 5 more...)